HIGHLIGHTS FROM ESGO & SGO 2024
Your direct line with Barcelona & San Diego
Welcome to the forefront of Gynaecological Oncology! Explore the latest advancements from two prestigious congresses shaping women’s cancer care.
This year, ESGO (European Society of Gynaecological Oncology), celebrates its 25th anniversary in Barcelona. And at the same time, the American Society of Gynecologic Oncology is holding it’s SGO Annual Meeting on Women’s Cancer in San Diego.
Join us to advance your clinical practice in gynaecological cancer treatment and care.
With the educational support of:
Congress highlights
Prof Jean-François Baurin, professor of medical oncology at Cliniques Universitaires Saint-Luc, UCLouvain, presents key updates from the SGO meeting in San Diego focusing on advancements in the treatment landscape
Professor Toon Van Gorp, a gynaecological oncologist at University Hospitals Leuven and current chair of the BGOG, provides a synopsis of key presentations on endometrial cancer at the ESGO congress.
The
Professor Mireille Langouo Fontsa, medical oncologist at the Institut Jules Bordet, offers a comprehensive summary of the pivotal findings on ovarian cancer unveiled at the ESGO congress.
The first scientific
Prof Jean-François Baurain, professor of medical oncology at Cliniques Universitaires Saint-Luc UC Louvain, provides insights from the SGO meeting in San Diego, focusing on advancements in the treatment landscape for
Professor Hannelore Denys, a distinguished medical oncologist at the University Hospital Ghent, offers a comprehensive summary of the pivotal findings on cervical cancer unveiled at the ESGO and the SGO
In-depth
Dr Anne-Sofie De Crem, a fourth-year resident in gynaecology at Ghent University Hospital in Belgium, presents her ESGO2024 poster.
Dr De Crem introduces a novel device for assessing margins during
Professor Toon Van Gorp, an oncological gynaecologist from the University of Leuven, Belgium, proudly presents the oral presentation by Dr Liselore Loverix, one of his former PhD students, at ESGO
Professor Jean-François Baurain, medical oncologist at the Cliniques Universitaires Saint-Luc, presents the data of the DUO-E trial in endometrial cancer at the SGO congress.
This clinical trial, involving over 700
Emeritus Professor Ignace Vergote from the University of Leuven discusses the findings of the ENGOT-ov50/GOG-3029/INNOVATE-3 trial, which he presented at the ESGO congress.
This phase 3 trial focused on recurrent
In the spotlight
Professor Toon Van Gorp, an oncological gynaecologist from the University of Leuven, Belgium, discusses the latest findings from the NRG GY018 trial, which were presented at the 2024 SGO conference
Professor Toon Van Gorp, an oncological gynaecologist from the University of Leuven, Belgium, discusses two studies presented at SGO 2024 in San Diego. The AR1ZE and CHAR1ZMA studies examined the
Dr Laure-Anne Teuwen, medical oncologist at the University hospital of Antwerp, underscores the significance of the KEYNOTE-A18 study, which assesses the efficacy and safety of pembrolizumab in combination with concurrent